CADINHA & CO LLC recently filed their 13F report for the second quarter of 2022, which ended on 2022-06-30.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
900 FORT STREET MALL HONOLULU, HI 96813
As of the latest 13F report, the guru’s equity portfolio contained 96 stocks valued at a total of $447.00Mil. The top holdings were TLT(15.06%), JNJ(6.11%), and MRK(5.97%).
According to GuruFocus data, these were CADINHA & CO LLC’s top five trades of the quarter.
SPDR Dow Jones Industrial Average ETF
The guru established a new position worth 107,545 shares in ARCA:DIA, giving the stock a 5.37% weight in the equity portfolio. Shares traded for an average price of $345.78 during the quarter.
On 08/05/2022, SPDR Dow Jones Industrial Average ETF traded for a price of $326.06 per share and a market cap of $28.41Bil. The stock has returned -4.22% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
In terms of valuation, SPDR Dow Jones Industrial Average ETF has a price-earnings ratio of 16.36 and a price-book ratio of 3.45.
iShares Core S&P 500 ETF
During the quarter, CADINHA & CO LLC bought 75,006 shares of ARCA:IVV for a total holding of 129,494. The trade had a 4.9% impact on the equity portfolio. During the quarter, the stock traded for an average price of $445.9.
On 08/05/2022, iShares Core S&P 500 ETF traded for a price of $413.73 per share and a market cap of $305.17Bil. The stock has returned -5.80% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
In terms of valuation, iShares Core S&P 500 ETF has a price-earnings ratio of 18.22 and a price-book ratio of 3.50.
Accenture PLC
CADINHA & CO LLC reduced their investment in NYSE:ACN by 57,217 shares. The trade had a 3.19% impact on the equity portfolio. During the quarter, the stock traded for an average price of $337.27.
On 08/05/2022, Accenture PLC traded for a price of $307.98 per share and a market cap of $193.85Bil. The stock has returned -3.11% over the past year.
GuruFocus gives the company a financial strength rating of 8 out of 10 and a profitability rating of 10 out of 10.
In terms of valuation, Accenture PLC has a price-earnings ratio of 29.73, a price-book ratio of 9.06, a price-earnings-to-growth (PEG) ratio of 2.61, a EV-to-Ebitda ratio of 17.40 and a price-sales ratio of 3.31.
The price-to-GF Value ratio is 0.95, earning the stock a GF Value rank of 6.
BHP Group Ltd
During the quarter, CADINHA & CO LLC bought 253,819 shares of NYSE:BHP for a total holding of 263,594. The trade had a 2.82% impact on the equity portfolio. During the quarter, the stock traded for an average price of $68.11.
On 08/05/2022, BHP Group Ltd traded for a price of $53.17 per share and a market cap of $189.38Bil. The stock has returned -12.66% over the past year.
GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 9 out of 10.
In terms of valuation, BHP Group Ltd has a price-earnings ratio of 8.43, a price-book ratio of 2.71, a price-earnings-to-growth (PEG) ratio of 0.41, a EV-to-Ebitda ratio of 5.77 and a price-sales ratio of 2.25.
The price-to-GF Value ratio is 0.77, earning the stock a GF Value rank of 10.
Thermo Fisher Scientific Inc
CADINHA & CO LLC reduced their investment in NYSE:TMO by 30,653 shares. The trade had a 2.76% impact on the equity portfolio. During the quarter, the stock traded for an average price of $574.18.
On 08/05/2022, Thermo Fisher Scientific Inc traded for a price of $585.77 per share and a market cap of $230.96Bil. The stock has returned 9.69% over the past year.
GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 10 out of 10.
In terms of valuation, Thermo Fisher Scientific Inc has a price-earnings ratio of 31.40, a price-book ratio of 5.45, a price-earnings-to-growth (PEG) ratio of 1.34, a EV-to-Ebitda ratio of 21.47 and a price-sales ratio of 5.45.
The price-to-GF Value ratio is 0.96, earning the stock a GF Value rank of 6.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
